➢ Glucagon-like peptide-1 (GLP-1) receptor agonists are a promising tool for preoperative weight loss in the patient who is undergoing orthopaedic surgery and has concomitant obesity and type-2 diabetes mellitus. ➢ With regard to the perioperative management of GLP-1 receptor agonists for the orthopaedic surgeon, the American Society of Anesthesiologists (ASA) recommends withholding daily-dose GLP-1 therapy on the day of the elective surgical procedure and withholding weekly-dose therapy for the week prior to the procedure. ➢ The ASA recommends postponing surgery or proceeding with “full stomach precautions” if the patient undergoing an orthopaedic procedure and taking GLP-1 therapy exhibits gastrointestinal symptoms on the day of the elective procedure. ➢ In the trauma setting, patients taking GLP-1 therapy should proceed with the surgical procedure at the discretion of the surgeon with full stomach precautions or a preoperative point-of-care gastric ultrasound. ➢ GLP-1 receptor agonists show the potential for disease modification in osteoarthritis and osteoporosis.
Military Medicine is AMSUS’ monthly peer-reviewed journal, with articles including scientific papers, case reports, and editorials. Its objective is to promote awareness of federal medicine by providing a forum for responsible discussion of common ideas and problems relevant to federal healthcare.
Glenoid bone loss can be a challenging problem to address surgically in patients with glenohumeral joint arthritis and concomitant end-stage rotator cuff deficiency. Reverse total shoulder arthroplasty (rTSA) has emerged as a treatment to restore function in this patient population and has demonstrated good clinical outcomes. Addressing bone loss is essential to prevent complication such as glenoid baseplate loosening, scapular notching, and instability. Metal augmentation of glenoid baseplates has shown good clinical and functional outcomes with low complication rates. This systematic review analyzes the outcomes of patients undergoing rTSA with augmented baseplates vs. those treated with a standard glenoid baseplate. Pain, range of motion, patient reported outcomes scores, complication, and revision rates were assessed. Four online literature databases (PubMed, MEDLINE, ScienceDirect, Scopus) were searched from database inception to July 1, 2024, for comparative studies evaluating outcomes between augmented and standard rTSA. Functional and clinical outcomes along with complication and revision rates were collected across studies. Frequency weighted means were used to synthesize data where appropriate. Five manuscripts met final criteria for inclusion encompassing 2,331patients with a mean age of 71.3 years and mean follow-up time of 38.8 months. When compared to the standard baseplate group or those treated with bone graft augmentation, the metal augmentation group had comparable improvement in frequency weight means in forward elevation, abduction, and external rotation. Similarly, frequency weighted means of improvement were comprable in the augmented group with regards to American Shoulder and Elbow Surgeons, Simple Shoulder Test, and Constant scores. In studies directly comparing augmented to nonaugmented rTSA, there was a total of 167 (7.5%) reported complications: 132 (7.8%) in the standard and 35 (6.7%) in the augmented cohorts. This systematic review demonstrates similar functional and clinical outcomes with the use of augmented glenoid baseplates to address glenoid bone loss in rTSA when compared to standard baseplates. Complications were comparable in the augmented baseplate group, with no difference in revision rates. These findings illustrate that augmented baseplates not only address bony defects but can provide good clinical and functional outcomes without the risk of increased complication in rTSA.
7 April 2026 in The American Journal of Sports Medicine
Background: Previous literature has demonstrated that an increased number of preoperative anterior shoulder instability episodes is associated with recurrent anterior shoulder instability after arthroscopic Bankart repair (ABR). However, a threshold for the number of preoperative instability episodes that increases the risk of recurrent anterior shoulder instability is not well established. Purpose: To establish a threshold value for the number of preoperative instability episodes that predicts recurrent anterior shoulder instability after ABR and to compare glenoid bone loss, the Hill-Sachs interval, and the distance to dislocation between patients who have surpassed the threshold and those who have not. Study Design: Retrospective cohort study; Level of evidence, 3. Methods: This retrospective review included consecutive patients with “on-track” Hill-Sachs lesions who underwent primary ABR for anterior shoulder instability at a single institution between 2007 and 2019. Patients with an unknown number of preoperative instability episodes, >20% glenoid bone loss, 40 or <14 years were excluded. Logistic regression assessed associations between preoperative anterior shoulder instability episodes and recurrent anterior shoulder instability after ABR, defined as a recurrent subluxation or dislocation. Receiver operating characteristic analysis determined the optimal threshold of preoperative anterior shoulder instability episodes to predict recurrent anterior shoulder instability. Significance was set as P < .050. Results: A total of 151 patients (mean age, 20 ± 5 years; mean follow-up, 6.0 ± 3.1 years) were included, of whom 28 (19%) experienced recurrent anterior shoulder instability. Multiple thresholds showed increased odds of recurrent anterior shoulder instability: ≥2 preoperative anterior shoulder instability events (odds ratio [OR], 9.70 [95% CI, 2.63-35.70]; P = .001), ≥3 events (OR, 3.47 [95% CI, 1.37-8.80]; P = .009), and ≥4 events (OR, 3.08 [95% CI, 1.17-8.08]; P = .023). Receiver operating characteristic analysis revealed that ≥2 preoperative anterior shoulder instability events was the strongest predictor of recurrent anterior shoulder instability (area under the curve = 0.72). Conclusion: A threshold of ≥2 preoperative anterior shoulder instability episodes best predicted recurrent anterior shoulder instability after ABR. Stratification beyond 1 versus ≥2 preoperative anterior shoulder instability episodes did not increase predictive ability. This finding may help surgeons to counsel patients and consider earlier surgical stabilization in those who have sustained anterior shoulder instability episodes.
Reducing hospital readmissions postspine surgery is crucial for improving care quality. Currently, no specific scoring system exists to stratify patients by readmission risk in spine surgery. The objective of this study was to evaluate risk factors for 30-day hospital readmission following elective decompressive spine surgery and develop an ML-based risk-scoring system. 653 patients undergoing elective decompressive spine surgery (with or without fusion) at a single academic center were retrospectively reviewed. Data collected included demographics, surgical details, preoperative admissions, and complications. Univariate logistic and Cox regression analyses identified significant predictors. A supervised ML-based risk scoring system was developed and compared against the institution’s standard risk calculator. Of 653 patients, 44 (6.7%) experienced a 30-day readmission. Predictors of readmission included prior-year hospital admission, age-adjusted Charlson Comorbidity Index (CCI), traumatic or thoracic surgery, postoperative complications, and length of stay. An ML-based scoring system stratified patients into Low-risk (0–4 points; 2.16% readmission), Moderate-risk (5–9 points; 7.25%), High-risk (10–14 points; 21.57%), and Extreme-risk (15+ points; 39.47%) groups. Compared to the standard hospital score, the new model demonstrated superior performance: higher C-index (0.79 vs. 0.71), higher Somers’ D (0.56 vs. 0.41), and lower Akaike Information Criterion (AIC) (516.78 vs. 546.65). Preoperative admission within 1 year prior to elective decompressive spine surgery significantly predicts 30-day readmission risk. Additional factors include age-adjusted CCI, traumatic or thoracic surgery, complications, and length of hospital stay. The proposed ML-based scoring system demonstrated superior predictive performance compared to the standard hospital readmission risk calculator, serving as a potentially valuable internal quality improvement tool pending external validation.